Sort by:

• Highly Influential Citations
• Citations
• Acceleration
• Velocity
• Recency

Learn More

Safety and One-Year revascularization outcome of excimer laser ablation therapy in treating in-stent restenosis of femoropopliteal arteries: A retrospective review from a single center.

• Nicolas W Shammas, Gail A. Shammas, Alexander K. Hafez, Ryan Kelly, Emily Reynolds, Andrew N Shammas
• Cardiovascular revascularization medicine…
• 2012

BACKGROUND Treatment of in-stent restenosis of the femoropopliteal (FP) arteries is challenging with a high rate of restenosis. Excimer laser atherectomy (ELA) has a theoretical advantage of ablating… (More)

Major Limb Outcomes Following Lower Extremity Endovascular Revascularization in Patients With and Without Diabetes Mellitus.

• Andrew N Shammas, Haekyung Jeon-Slaughter, +8 authors Subhash Banerjee
• Journal of endovascular therapy : an official…
• 2017

PURPOSE To determine whether diabetes mellitus has an independent impact on major limb outcomes at 1 year after endovascular treatment of lower extremity peripheral artery disease (PAD). METHODS… (More)

Safety and Effectiveness of Closure Devices Applied to a Stented Common Femoral Artery: A Retrospective Analysis.

• Nicolas W Shammas, Gail A. Shammas, Thomas Harris, Cara M Voelliger, Andrew N Shammas, Michael J. Jerin
• The International journal of angiology : official…
• 2016

Bailout stenting of the common femoral artery (CFA) may become necessary with failed balloon angioplasty or atherectomy or in case of bleeding requiring a covered stent over the arteriotomy site.… (More)

In-hospital safety and effectiveness of bivalirudin in percutaneous peripheral interventions: data from a real-world registry.

• Nicolas W Shammas, Gail A. Shammas, Michael J. Jerin, Eric J Dippel, Andrew N Shammas
• Journal of endovascular therapy : an official…
• 2010

PURPOSE To present real-world data to evaluate the safety and effectiveness of bivalirudin, a direct thrombin inhibitor, in an unselected group of patients undergoing percutaneous peripheral… (More)

Five-Year Freedom From Target-Lesion Revascularization Using Excimer Laser Ablation Therapy in the Treatment of In-Stent Restenosis of Femoropopliteal Arteries.

• Nicolas W Shammas, Gail A. Shammas, +4 authors Benjamin Rudy
• The Journal of invasive cardiology
• 2017

BACKGROUND Target-lesion revascularization (TLR) and loss of patency remain high following treatment of in-stent restenosis (ISR) of the femoropopliteal (FP) artery. Excimer laser atherectomy (ELA)… (More)

The learning curve in treating coronary chronic total occlusion early in the experience of an operator at a tertiary medical center: The role of the hybrid approach.

• Nicolas W Shammas, Gail A. Shammas, +6 authors Michael J. Jerin
• Cardiovascular revascularization medicine…
• 2016

BACKGROUND Treatment of chronic total occlusion (CTO) is complex and has a low adoption rate by interventional cardiologists. The introduction of the hybrid approach has provided a systematic… (More)

Predictors of common femoral artery access site complications in patients on oral anticoagulants and undergoing a coronary procedure

• Nicolas W Shammas, Gail A. Shammas, +11 authors Andrew N Shammas
• Therapeutics and clinical risk management
• 2017

BACKGROUND It is unclear whether patients on oral anticoagulants (OAC) undergoing a procedure using common femoral artery access have higher adverse events when compared to patients who are not… (More)

• ‹
• 1
• ›